Additionally, we observed significantly decreased Tnfα and Il1β at the end of the infection, suggesting that SP receptor antagonism reduced bacterial burden and pathology leading to lasting effects in the host after the pathogen was cleared. The gene discussed is IL1B; the disease is infection.